← Back to Search

Virtual Warrior Renew Therapy for Military Sexual Trauma

N/A
Recruiting
Led By Amanda E Wood, PhD
Research Sponsored by Seattle Institute for Biomedical and Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes from baseline at week 16
Awards & highlights

Study Summary

This trial studies two group therapies for Veterans w/ MST to reduce mental health symptoms. Results will show if either is more effective than the other. Participation takes 16 weeks.

Who is the study for?
This trial is for Veterans aged 18-75 who have experienced military sexual trauma and are currently receiving care from a VA provider. They must be able to attend virtual group therapy, speak English, and not have severe mental health conditions like schizophrenia or active substance abuse disorders.Check my eligibility
What is being tested?
The study compares two group therapies: Warrior Renew and Health & Wellness, to see which is more effective at reducing mental health symptoms in Veterans with military sexual trauma. Participants will engage in one of these treatments over the course of 16 weeks.See study design
What are the potential side effects?
Since this trial involves psychological group therapies rather than medications, traditional side effects are not expected. However, participants may experience emotional discomfort or distress while discussing traumatic experiences during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes from baseline at week 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes from baseline at week 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PTSD Checklist for DSM-5
PTSD Checklist for DSM-5 (PCL-5)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Warrior RenewExperimental Treatment1 Intervention
8 weeks, once weekly 90 minute sessions, groups of 8-10 subjects, gender stratified
Group II: Health & WellnessActive Control1 Intervention
8 weeks, once weekly 90 minute sessions, groups of 8-10 subjects, gender stratified

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
865 Previous Clinical Trials
327,565 Total Patients Enrolled
Seattle Institute for Biomedical and Clinical ResearchLead Sponsor
52 Previous Clinical Trials
13,266 Total Patients Enrolled
Amanda E Wood, PhDPrincipal InvestigatorVA Puget Sound Health Care System
1 Previous Clinical Trials
20 Total Patients Enrolled

Media Library

Warrior Renew Clinical Trial Eligibility Overview. Trial Name: NCT05776719 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Warrior Renew, Health & Wellness
Post-Traumatic Stress Disorder Clinical Trial 2023: Warrior Renew Highlights & Side Effects. Trial Name: NCT05776719 — N/A
Warrior Renew 2023 Treatment Timeline for Medical Study. Trial Name: NCT05776719 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation open to participants aged 45 and over?

"This medical study is open to participants aged 18 or above and below the age of 75."

Answered by AI

Are there any current vacancies in this exploration for individuals?

"Clinicaltrials.gov verifies that this clinical trial is actively enrolling patients, commencing on May 15th 2023 and having last been modified June 13th 2023."

Answered by AI

How many individuals are being treated through this research endeavor?

"Affirmative. Per the data on clinicaltrials.gov, this research initiative is in need of applicants and was initially posted on May 15th 2023 with a subsequent update June 13th 2023. 134 volunteers must be recruited from 3 distinct medical centres."

Answered by AI

Are there any qualifications for participating in this research?

"Being accepted into this clinical trial necessitates the applicant have PTSD and meet age criteria between 18 to 75 years old. A total of 134 patients are required for enrolment."

Answered by AI
~89 spots leftby Nov 2026